Compare DCI Indonesia Tbk (DCII) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DCI Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? DCI Indonesia Tbk trades at Rp198,675 (market cap 473.71T, 1K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: DCI Indonesia Tbk is far larger — about 2830.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (71K versus 1K). Which is the better fit depends on your goals.
| DCII | OBAT | |
|---|---|---|
Market Cap | 473.71T | 167.37B |
Volume | 1K | 71K |
Lot | 10 | 710 |
Turnover | 194.12M | 17.51M |
Average Price | 194,120 | 246.63 |
Value | 194.12M | 17.51M |
Indicative Equilibrium Price | 199,000 | 246 |
Indicative Equilibrium Volume | 1 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DCI Indonesia Tbk
PT DCI Indonesia Tbk (the Company) was established in Indonesia based on Notarial Deed No. 143 of Buntario Tigris, S.H., S.E., M.H., on July 18, 2011. The Company started its commercial operations in 2013. The Company parent entity and ultimate controlling party is DCI International Holding Pte. Ltd., Singapore.
Read more on DCII →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
